Clinical Trial Update: Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports an early-phase 1 study of sorafenib in patients undergoing surgery for stage II–IV kidney cancer, and the trial has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Kidney Cancer | EARLY_Phase 1 | Status: COMPLETED